Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.68 |
| ▸ | HPGD | P15428 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | MITF | O75030 | 1/20 | 0.68 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | GAA | P10253 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ESRRG | P62508 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26935149 | 1.00 | MAPT (0.68) | MAPTHPGDALDH1A1SMN1; SMN2MITF | |
| SCHEMBL11388177 | 0.85 | NOX1 (0.91) | MAPTHPGDALDH1A1SMN1; SMN2NOX1 | |
| SCHEMBL11388174 | 0.85 | NOX1 (0.91) | MAPTHPGDALDH1A1SMN1; SMN2NOX1 | |
| SCHEMBL26935005 | 0.82 | MAPT (1.00) | MAPTHPGDALDH1A1SMN1; SMN2MITF | |
| SCHEMBL26915313 | 0.82 | MAPT (1.00) | MAPTHPGDALDH1A1SMN1; SMN2MITF | |
| SCHEMBL42159 | 0.81 | NOX1 (1.00) | MAPTHPGDALDH1A1SMN1; SMN2NOX1 | |
| SCHEMBL22874080 | 0.81 | NOX1 (1.00) | MAPTHPGDALDH1A1SMN1; SMN2NOX1 | |
| SCHEMBL42160 | 0.81 | NOX1 (1.00) | MAPTHPGDALDH1A1SMN1; SMN2NOX1 | |
| SCHEMBL29859752 | 0.80 | MAPT (0.72) | MAPTHPGDALDH1A1SMN1; SMN2MITF | |
| SCHEMBL26935144 | 0.80 | MAPT (0.72) | MAPTHPGDALDH1A1SMN1; SMN2MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240139214-A1 | AGENT FOR SUPPRESSING IL-31 PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-05-02 | — | — | US | disclosed |
| EP-4289422-A1 | AGENT FOR SUPPRESSING IL-31 PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Kyushu University, National University Corporation (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-117042759-A | IL-31 production inhibitor and pharmaceutical composition containing the same | 国立大学法人九州大学 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022168962-A1 | AGENT FOR SUPPRESSING IL-31 PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | 国立大学法人九州大学 | 2022-08-11 | — | — | WO | disclosed |
| US-7691929-B2 | Flame retardant compositions | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090186970-A1 | Flame retardant compositions | RONAN NICOLAS | 2009-07-23 | — | — | US | disclosed |
| EP-1668073-B1 | FLAME RETARDANT COMPOSITIONS | CIBA HOLDING INC (CH) | 2009-04-29 | — | — | EP | disclosed |
| US-20070029531-A1 | Flame retardant compositions | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-08 | — | — | US | disclosed |
| EP-1668073-A2 | FLAME RETARDANT COMPOSITIONS | Ciba SC Holding AG (CH) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005030852-A2 | FLAME RETARDANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139214-A1 | AGENT FOR SUPPRESSING IL-31 PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | IL36G, IL1RN, IL1B | MAPT 3812/4885HPGD 622/4885ALDH1A1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.